查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1671179

全球老年藥物市場、規模、佔有率、趨勢、行業分析報告：依治療藥物、疾病狀況、通路和地區 - 市場預測（2025-2034）

Global Geriatric Medicines Market Size, Share, Trends, Industry Analysis Report: By Therapeutics, Condition, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，全球老年藥品市場預計到2034年將達到 3,405億美元。本研究報告對當前市場動態提供了詳細的見解，並對未來市場成長進行了分析。

老年醫學，也稱為老年藥物治療，是指致力於開發、使用和管理專門針對老年人的藥物治療的醫學專業。該領域解決與老化相關的獨特的生理變化和健康挑戰，包括心血管疾病、糖尿病、關節炎、神經系統疾病和呼吸系統疾病等慢性疾病。

老年醫學藥品市場受到全球老齡化人口不斷成長以及心血管疾病、糖尿病、關節炎和神經退化性疾病等慢性病和與年齡相關的疾病患病率上升的推動。該市場的關鍵商業機會包括個人化醫療的進步、針對特定年齡的藥物配方的開發以及新興市場的醫療保健基礎設施的擴展。

遠距醫療和穿戴式裝置等數位健康科技的整合等趨勢改善老年人獲得照護的機會和治療依從性。預防藥物和生物相似藥的投資也在增加，因為它們提供了具有成本效益的解決方案。總體而言，隨著全球對創新和可及治療的需求不斷上升，老年藥品市場預計將穩定成長。

老年藥物市場報告重點

由於老年族群糖尿病盛行率較高，抗糖尿病藥物佔據市場主導地位，其成長動力來自於對 GLP-1 受體促效劑等創新治療藥物的需求不斷成長。

由於老年人心臟相關疾病的負擔很重，心血管疾病佔據了最大的市場佔有率，而由於阿茲海默症和帕金森氏症的盛行率不斷上升，神經系統疾病的市場佔有率成長最快。

另一方面，由於送貨上門的便利性和數位健康平台的日益普及，網路藥局快速成長。

受先進醫療基礎設施和老年人口不斷成長的推動，北美佔據市場主導地位。同時，由於老齡人口不斷增加和醫療保健條件不斷改善，亞太地區是成長最快的地區。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球老年藥物市場洞察

  • 市場概況
  • 老年藥物市場動態
    • 驅動因素和機會
      • 對與年齡相關的藥物的需求不斷增加
      • 為老年患者推廣個人化醫療
    • 阻礙因素和挑戰
      • 老年人的醫療費用高昂
  • PESTEL 分析
  • 老年醫學市場的應用趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第5章 全球老年醫學市場：依治療藥

  • 主要調查結果
  • 簡介
  • 止痛藥
  • 他汀類藥物
  • 抗糖尿病藥物
  • 質子幫浦抑制劑（PPI）
  • 抗凝血劑
  • 抗精神病藥物
  • 其他

第6章 全球老年醫學市場：依疾病狀況

  • 主要調查結果
  • 簡介
  • 心血管疾病
  • 神經系統疾病
  • 癌症
  • 糖尿病與代謝紊亂
  • 呼吸系統疾病
  • 其他

第7章 全球老年醫學藥品市場：依通路

  • 主要調查結果
  • 簡介
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第8章 全球老年醫學藥品市場：依地區

  • 主要調查結果
  • 簡介
    • 老年藥物市場評估，地區，2020年至2034年
  • 北美洲
    • 北美：依治療劑分類，2020年至2034年
    • 北美：依疾病類型，2020年至2034年
    • 北美：依通路， 2020年至2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依治療劑分類，2020年至2034年
    • 歐洲：依疾病類型，2020年至2034年
    • 歐洲：依通路， 2020年至2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 亞太地區：依治療劑分類，2020年至2034年
    • 亞太地區：依疾病類型，2020年至2034年
    • 亞太地區：依通路， 2020年至2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東和非洲
    • 中東和非洲：依治療劑分類，2020年至2034年
    • 中東和非洲：依疾病類型，2020年至2034年
    • 中東和非洲：依通路， 2020年至2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 拉丁美洲：依治療劑分類，2020年至2034年
    • 拉丁美洲：依疾病類型，2020年至2034年
    • 拉丁美洲：依通路， 2020年至2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第9章 競爭格局

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/公開

第10章 公司簡介

  • Pfizer Inc.
  • Novartis International AG
  • Sanofi
  • GlaxoSmithKline
  • Merck & Co.
  • AbbVie
  • AstraZeneca
  • Johnson & Johnson
  • Eli Lilly and Company
  • Roche
Product Code: PM1338

The global geriatric medicines market size is expected to reach USD 340.50 billion by 2034, according to a new study by Polaris Market Research. The report "Geriatric Medicines Market Size, Share, Trends, Industry Analysis Report: By Therapeutics (Analgesics, Statins, Antidiabetic, Proton Pump Inhibitors (PPIs), Anticoagulant, Antipsychotic, and Others), Condition, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Geriatric medicines, also known as geriatric pharmacotherapy, refer to a specialized branch of medicine focused on the development, use, and management of pharmaceutical treatments designed specifically for elderly individuals. This area addresses the unique physiological changes and health challenges associated with aging, including chronic conditions such as cardiovascular diseases, diabetes, arthritis, neurological disorders, and respiratory diseases.

The geriatric medicines market is driven by the growing global aging population and the rising prevalence of chronic and age-related diseases such as cardiovascular conditions, diabetes, arthritis, and neurodegenerative disorders. Key opportunities in the market include advancements in personalized medicine, the development of age-specific drug formulations, and the expansion of healthcare infrastructure in emerging markets.

Trends such as the integration of digital health technologies, including telemedicine and wearable devices, are enhancing access to care and improving treatment adherence among older adults. The market is also seeing increasing investments in preventive healthcare and biosimilars to provide cost-effective solutions. Overall, the geriatric medicines market is poised for steady growth as demand for innovative and accessible treatments continues to rise globally.

Geriatric Medicines Market Report Highlights

The antidiabetic segment dominates the market due to the high prevalence of diabetes among the elderly, with rising demand for innovative treatments such as GLP-1 receptor agonists driving growth.

Cardiovascular diseases account for the largest geriatric medicines market share, driven by the significant burden of heart-related conditions in older adults, while neurological disorders are the fastest-growing segment due to the increasing prevalence of Alzheimer's and Parkinson's diseases.

Hospital pharmacies lead the market as they are primary points of care for elderly patients with chronic diseases, whereas online pharmacies are registering the fastest growth due to the convenience of home delivery and the rising adoption of digital health platforms.

North America dominates the market, supported by advanced healthcare infrastructure and a growing elderly population, while Asia Pacific is the fastest-growing region, fueled by its expanding geriatric demographic and improving healthcare access.

Polaris Market Research has segmented the geriatric medicines market report based on therapeutics, condition, distribution channel, and region:

By Therapeutics Outlook (Revenue-USD Billion, 2020 - 2034)

  • Analgesics
  • Statins
  • Antidiabetic
  • Proton Pump Inhibitors (PPIs)
  • Anticoagulant
  • Antipsychotic
  • Others

By Condition Outlook (Revenue-USD Billion, 2020 - 2034)

  • Cardiovascular Diseases
  • Neurological Disorders
  • Cancer
  • Diabetes & Metabolic Disorders
  • Respiratory Diseases
  • Others

By Distribution Channel Outlook (Revenue-USD Billion, 2020 - 2034)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Regional Outlook (Revenue-USD Billion, 2020 - 2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Geriatric Medicines Market Insights

  • 4.1. Geriatric Medicines Market - Market Snapshot
  • 4.2. Geriatric Medicines Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Demand for Age-Specific Medications
      • 4.2.1.2. Advancements in Personalized Medicine for Elderly Patients
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Geriatric Healthcare
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Geriatric Medicines Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Geriatric Medicines Market, by Therapeutics

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • 5.3. Analgesics
    • 5.3.1. Global Geriatric Medicines Market, by Analgesics, by Region, 2020-2034 (USD Billion)
  • 5.4. Statins
    • 5.4.1. Global Geriatric Medicines Market, by Statins, by Region, 2020-2034 (USD Billion)
  • 5.5. Antidiabetic
    • 5.5.1. Global Geriatric Medicines Market, by Antidiabetic, by Region, 2020-2034 (USD Billion)
  • 5.6. Proton Pump Inhibitors (PPIs)
    • 5.6.1. Global Geriatric Medicines Market, by Proton Pump Inhibitors (PPIs), by Region, 2020-2034 (USD Billion)
  • 5.7. Anticoagulant
    • 5.7.1. Global Geriatric Medicines Market, by Anticoagulant, by Region, 2020-2034 (USD Billion)
  • 5.8. Antipsychotic
    • 5.8.1. Global Geriatric Medicines Market, by Antipsychotic, by Region, 2020-2034 (USD Billion)
  • 5.9. Others
    • 5.9.1. Global Geriatric Medicines Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Geriatric Medicines Market, by Condition

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • 6.3. Cardiovascular Diseases
    • 6.3.1. Global Geriatric Medicines Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
  • 6.4. Neurological Disorders
    • 6.4.1. Global Geriatric Medicines Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
  • 6.5. Cancer
    • 6.5.1. Global Geriatric Medicines Market, by Cancer, by Region, 2020-2034 (USD Billion)
  • 6.6. Diabetes & Metabolic Disorders
    • 6.6.1. Global Geriatric Medicines Market, by Diabetes & Metabolic Disorders, by Region, 2020-2034 (USD Billion)
  • 6.7. Respiratory Diseases
    • 6.7.1. Global Geriatric Medicines Market, by Respiratory Diseases, by Region, 2020-2034 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Geriatric Medicines Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Geriatric Medicines Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Geriatric Medicines Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Geriatric Medicines Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Geriatric Medicines Market, by Online Pharmacy, by Region, 2020-2034 (USD Billion)

8. Global Geriatric Medicines Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Geriatric Medicines Market Assessment, b y Geography, 2020-2034 (USD Billion)
  • 8.3. Geriatric Medicines Market - North America
    • 8.3.1. North America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.3.2. North America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.3.3. North America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.4. Geriatric Medicines Market - US
      • 8.3.4.1. US : Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.3.4.2. US : Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.3.4.3. U S: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.5. Geriatric Medicines Market - Canada
      • 8.3.5.1. Canada: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.4. Geriatric Medicines Market - Europe
    • 8.4.1. Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.4. Geriatric Medicines Market - UK
      • 8.4.4.1. UK: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.5. Geriatric Medicines Market - France
      • 8.4.5.1. France: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.6. Geriatric Medicines Market - Germany
      • 8.4.6.1. Germany: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.7. Geriatric Medicines Market - Italy
      • 8.4.7.1. Italy: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.8. Geriatric Medicines Market - Spain
      • 8.4.8.1. Spain: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.9. Geriatric Medicines Market - Netherlands
      • 8.4.9.1. Netherlands: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.10. Geriatric Medicines Market - Russia
      • 8.4.10.1. Russia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.11. Geriatric Medicines Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.5. Geriatric Medicines Market - Asia Pacific
    • 8.5.1. Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.4. Geriatric Medicines Market - China
      • 8.5.4.1. China: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.5. Geriatric Medicines Market - India
      • 8.5.5.1. India: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.6. Geriatric Medicines Market - Malaysia
      • 8.5.6.1. Malaysia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.7. Geriatric Medicines Market - Japan
      • 8.5.7.1. Japan: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.8. Geriatric Medicines Market - Indonesia
      • 8.5.8.1. Indonesia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.9. Geriatric Medicines Market - South Korea
      • 8.5.9.1. South Korea: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.10. Geriatric Medicines Market - Australia
      • 8.5.10.1. Australia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.11. Geriatric Medicines Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.6. Geriatric Medicines Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.4. Geriatric Medicines Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.5. Geriatric Medicines Market - UAE
      • 8.6.5.1. UAE: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.6. Geriatric Medicines Market - Israel
      • 8.6.6.1. Israel: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.7. Geriatric Medicines Market - South Africa
      • 8.6.7.1. South Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.8. Geriatric Medicines Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.7. Geriatric Medicines Market - Latin America
    • 8.7.1. Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.4. Geriatric Medicines Market - Mexico
      • 8.7.4.1. Mexico: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.5. Geriatric Medicines Market - Brazil
      • 8.7.5.1. Brazil: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.6. Geriatric Medicines Market - Argentina
      • 8.7.6.1. Argentina: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.7. Geriatric Medicines Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Pfizer Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Novartis International AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Sanofi
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. GlaxoSmithKline
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Merck & Co.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. AbbVie
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. AstraZeneca
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Eli Lilly and Company
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Roche
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 2 Global Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 3 Global Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 4 North America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 5 North America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 6 North America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 7 U.S.: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 8 U.S.: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 9 U.S.: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 Canada: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 11 Canada: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 12 Canada: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 14 Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 15 Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 16 UK: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 17 UK: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 18 UK: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 19 France: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 20 France: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 21 France: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 22 Germany: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 23 Germany: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 24 Germany: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Italy: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 26 Italy: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 27 Italy: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 28 Spain: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 29 Spain: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 30 Spain: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 34 Russia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 35 Russia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 36 Russia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 43 China: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 44 China: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 45 China: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 46 India: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 47 India: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 48 India: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 52 Japan: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 53 Japan: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 54 Japan: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 58 South Korea: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 59 South Korea: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 60 South Korea: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Australia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 62 Australia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 63 Australia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 73 UAE: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 74 UAE: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 75 UAE: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 76 Israel: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 77 Israel: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 78 Israel: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 79 South Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 80 South Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 81 South Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 86 Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 87 Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 88 Mexico: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 89 Mexico: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 90 Mexico: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 91 Brazil: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 92 Brazil: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 93 Brazil: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 94 Argentina: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 95 Argentina: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 96 Argentina: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Geriatric Medicines Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapeutics
  • Figure 7. Global Geriatric Medicines Market, by Therapeutics, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Condition
  • Figure 9. Global Geriatric Medicines Market, by Condition, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Geriatric Medicines Market, by Distribution Channel, 2024 & 2034 (USD Billion)